Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antimicrobial resistance in Staphylococcus aureus.

T L Smith1, W R Jarvis

  • 1Hospital Infections Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA.

Microbes and Infection
|May 18, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corticosteroid responsive olfactory dysfunction in chronic rhinosinusitis: what does it mean?

Rhinology·2025
Same author

Consensus criteria for chronic rhinosinusitis disease control: an international Delphi Study.

Rhinology·2023
Same author

The Olfactory Cleft Endoscopy Scale: a multi-institutional validation study in chronic rhinosinusitis.

Rhinology·2020
Same author

Lack of impact of radiologic septal measurements upon patient symptoms and performance of septoplasty during endoscopic sinus surgery.

Rhinology·2020
Same author

European Position Paper on Rhinosinusitis and Nasal Polyps 2020.

Rhinology·2020
Same author

Therapeutic targeting of membrane-associated GRP78 in leukemia and lymphoma: preclinical efficacy in vitro and formal toxicity study of BMTP-78 in rodents and primates.

The pharmacogenomics journal·2017

Staphylococcus aureus infections are a growing threat due to antimicrobial resistance. Understanding resistance is key to effectively treating these dangerous infections and preventing a return to high mortality rates.

Area of Science:

  • Microbiology and Infectious Diseases
  • Antimicrobial Resistance Research
  • Clinical Medicine

Background:

  • Staphylococcus aureus has been a recognized cause of infection since 1883.
  • The pre-antimicrobial era saw an 82% mortality rate for S. aureus bacteremia.
  • Emerging vancomycin resistance in S. aureus threatens to reverse treatment successes.

Purpose of the Study:

  • To highlight the increasing threat of Staphylococcus aureus infections.
  • To emphasize the critical need for understanding antimicrobial resistance in S. aureus.
  • To underscore the importance of this knowledge for successful treatment outcomes.

Main Methods:

  • Review of historical and current data on Staphylococcus aureus infections.
  • Analysis of trends in antimicrobial resistance, particularly vancomycin resistance.

Related Experiment Videos

  • Assessment of the impact of resistance on treatment efficacy and mortality rates.

    • Main Results:

    • Growing vancomycin resistance is undermining a key treatment for S. aureus.
    • The potential for a return to high mortality rates associated with S. aureus bacteremia.
    • Antimicrobial resistance capacity is a critical factor in treatment success.

    Conclusions:

    • Effective treatment of Staphylococcus aureus infections is increasingly challenging.
    • Knowledge of S. aureus antimicrobial resistance patterns is essential for clinical practice.
    • Proactive strategies are needed to combat rising resistance and improve patient outcomes.